OCPNF
Established in Tokyo, Japan, in 1919, Olympus Corporation is a global leader in the manufacturing and distribution of advanced precision machinery and scientific instruments. The company structures its diverse operations into four main segments. Its Endoscopic Solutions division provides sophisticated endoscopic tools for gastrointestinal and surgical procedures, along with complete endoscopy systems and crucial repair services. The Therapeutic Solutions segment delivers specialized medical devices for urology, gynecology, and otolaryngology (ear, nose, and throat), alongside endo-therapy and energy-based devices, and single-use surgical instruments. Under its Scientific Solutions umbrella, Olympus supplies an array of biological and industrial microscopes, industrial inspection equipment including endoscopes and videoscopes, non-destructive testing apparatus, and X-ray fluorescence (XRF) analyzers. The "Others" category encompasses biomedical materials and orthopedic equipment. Furthermore, Olympus's extensive offerings include additional medical technologies such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, supported by system integration and comprehensive maintenance and service programs. The company, which was originally known as Olympus Optical Co., Ltd., officially rebranded as Olympus Corporation in October 2003.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q4 | 22.37 | $297.1B | $30.3B |
| 2025 Q3 | 12.88 | $261.3B | $27.1B |
| 2025 Q2 | 18.09 | $247.8B | $16.4B |
| 2025 Q1 | 7.97 | $206.5B | -$28.3B |
| 2025 Q4 | 36.75 | $272.1B | $49.1B |
| 2024 Q3 | 23.74 | $251.2B | $22.4B |
| 2024 Q2 | 29.82 | $239.2B | $58.2B |
| 2024 Q1 | 12.68 | $234.8B |
| $14.8B |